August 27, 2016 12:40 AM ET

Pharmaceuticals

Company Overview of Sanofi

Executive Profile

Muzammil M. Mansuri Ph.D.

Executive Vice President of Strategy & Business Development, Sanofi
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
62--

Background

Dr. Muzammil M. Mansuri, also known as Muz, Ph.D., has been an Executive Vice President of Strategy & Business Development at Sanofi since February 22, 2016. Mr. Mansuri will be responsible for all Group strategic planning, business development, strategic intelligence, alliance management and the Sanofi Genzyme Bio Ventures fund. Dr. Mansuri served as Senior Vice President of Research, Development Strategy and Corporate Development at Gilead Sciences Inc. since April ...

Corporate Headquarters

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 42 96

Board Members Memberships

Independent Director
Executive Chairman
Director

Education

Doctorate
University Of London
PhD
University College London
BS
University College London

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John F. Milligan Ph.D.Chief Executive Officer, President and Director
Gilead Sciences Inc.
$1.2M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$1.0M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$3.3M
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
$21.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanofi, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.